Mainland Chinese investors are increasingly fueling momentum in Hong Kong listed biotechnology and pharmaceutical companies following a recent adjustment to the Stock Connect southbound trading list. The update now allows mainland investors to trade shares in more than a dozen additional biotech firms
Researchers in China have introduced a new motion control framework designed to significantly enhance the physical capabilities of humanoid robots. Developed by the Beijing Institute for General Artificial Intelligence, the system enables robots to perform a wide range of highly dynamic actions that
China has approved a new GLP 1 based drug developed by Pfizer for long term weight management in adults who are overweight or obese, marking another step in the rapid expansion of the country’s metabolic health treatment market. The approval allows the injectable
Chinese technology companies drew significant attention at the 2026 Mobile World Congress in Barcelona, presenting a wide range of innovations that highlighted the country’s expanding influence in advanced digital technologies. From artificial intelligence platforms to robotics systems and next generation mobile networks, Chinese
Hong Kong listed biotechnology company Insilico Medicine has expanded its global footprint through a new partnership in the United Arab Emirates aimed at accelerating artificial intelligence driven drug discovery. The agreement was signed with the UAE’s national drug regulator during a major healthcare
China and Hong Kong are being encouraged to relax listing requirements for biotechnology companies as investors seek to accelerate growth in the healthcare sector. Venture capital leaders and industry participants argue that regulatory adjustments could help innovative biotech firms gain faster access to
China’s biotechnology sector has recorded a sharp rise in international licensing deals during the opening months of 2026, highlighting the country’s growing influence in global pharmaceutical research and drug development. The total value of outlicensing agreements signed by Chinese biotech companies in the
Diagnostics startup Droplet Biosciences has announced a collaboration with Nvidia to accelerate the processing of genomic data used in post surgery cancer testing, aiming to significantly shorten the time patients wait for critical results. The company is integrating Nvidia’s GPU accelerated computing infrastructure,
Chinese artificial intelligence driven drug discovery firm XtalPi Holdings has projected its first full year profit following a sharp rise in revenue, signaling growing commercial traction for AI powered pharmaceutical research in China. The Shenzhen based company said it expects to report a
Chinese smartphone brand Honor has introduced a robot phone and its first humanoid companion as part of an aggressive expansion into artificial intelligence powered hardware, signaling a new phase of competition in the global Android ecosystem. The announcement came ahead of MWC Barcelona,
